Background Currently, preoperative staging of esophageal adenocarcinoma (EAC) has modest reliability and accuracy for pT and pN stages prediction, which heavily affects overall survival. The interplay among immune checkpoints, oncogenes, and intratumoral and peritumoral immune infiltrating cells could be used to predict loco-regional metastatic disease in early EAC. Methods We prospectively evaluated immune markers expression and oncogenes status as well as intratumoral and peritumoral immune infiltrating cells populations in esophageal mucosa samples obtained from neoadjuvant therapy-naive patients who had esophagectomy for EAC. Results Vascular invasion and high infiltration of lamina propria mononuclear cells resulted associated with nod...
Background. Esophageal cancer (EC) is a common malignant tumor of the digestive system with high mor...
BACKGROUND: The validation of novel prognostic indicators is of greatest interest for the management...
Background: Tumor infiltrating T-lymphocytes (TILs) have been shown to play an important prognostic ...
Introduction The inflammatory microenvironment has emerged as one of the focuses of cancer research....
Immunotherapy is a new anti-cancer treatment option, showing promising results in clinical trials. T...
Esophageal adenocarcinoma (EAC) is a disease with dismal treatment outcomes. Response to neoadjuvant...
Response rates to the current gold standards of care for treating oesophageal adenocarcinoma (OAC) r...
Esophageal cancer is the eighth most common cancer and the sixth leading cause of cancer death world...
Background Limited studies examine the immune landscape in Esophageal Adenocarcinoma (EAC). We aim t...
Esophageal adenocarcinoma (EAC) is a highly aggressive cancer and its response to chemo- and radioth...
Esophageal cancer is among the top ten most deadly cancers worldwide with adenocarcinomas of the eso...
Primary esophageal small cell carcinoma (PESCC) is a weakly prevalent but lethal malignancy with ear...
Abstract: Simple Summary Gene expression of esophageal adenocarcinoma is highly heterogeneous. In ge...
A low response rate limits the application of immune checkpoint inhibitors (ICIs) in the treatment o...
Perioperative chemotherapy enhances the survival rates for patients with esophageal and gastric (EG)...
Background. Esophageal cancer (EC) is a common malignant tumor of the digestive system with high mor...
BACKGROUND: The validation of novel prognostic indicators is of greatest interest for the management...
Background: Tumor infiltrating T-lymphocytes (TILs) have been shown to play an important prognostic ...
Introduction The inflammatory microenvironment has emerged as one of the focuses of cancer research....
Immunotherapy is a new anti-cancer treatment option, showing promising results in clinical trials. T...
Esophageal adenocarcinoma (EAC) is a disease with dismal treatment outcomes. Response to neoadjuvant...
Response rates to the current gold standards of care for treating oesophageal adenocarcinoma (OAC) r...
Esophageal cancer is the eighth most common cancer and the sixth leading cause of cancer death world...
Background Limited studies examine the immune landscape in Esophageal Adenocarcinoma (EAC). We aim t...
Esophageal adenocarcinoma (EAC) is a highly aggressive cancer and its response to chemo- and radioth...
Esophageal cancer is among the top ten most deadly cancers worldwide with adenocarcinomas of the eso...
Primary esophageal small cell carcinoma (PESCC) is a weakly prevalent but lethal malignancy with ear...
Abstract: Simple Summary Gene expression of esophageal adenocarcinoma is highly heterogeneous. In ge...
A low response rate limits the application of immune checkpoint inhibitors (ICIs) in the treatment o...
Perioperative chemotherapy enhances the survival rates for patients with esophageal and gastric (EG)...
Background. Esophageal cancer (EC) is a common malignant tumor of the digestive system with high mor...
BACKGROUND: The validation of novel prognostic indicators is of greatest interest for the management...
Background: Tumor infiltrating T-lymphocytes (TILs) have been shown to play an important prognostic ...